Close Menu

NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics and the World Hepatitis Alliance announced today that the two organizations will collaborate on advocacy and communication efforts in support of hepatitis C diagnostics.

Chronic hepatitis C infection can lead to liver damage, cirrhosis, and liver cancer. Worldwide, more than 71 million people are chronically infected, and approximately 80 percent live in low- and middle-income countries with only 1 in 5 people aware they are infected.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.